Stocks
Haemonetics Corporation (HAE) EBITDA US GAAP (year values) |
|||||||||
| 2022 | 2023 | 2023 | 2024 | 2024 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 169.5 | 249.3 | 249.3 | 305.4 | 263.0 | |||
| Changes by years, y/y, % | +19% | +47% | 0% | -100% | +9.6% | ||||
Haemonetics Corporation. EBITDA US GAAP, bln rub
Haemonetics Corporation. EBITDA US GAAP, changes, %
Haemonetics Corporation. EBITDA US GAAP, sum by quarters, bln rub
Haemonetics Corporation (HAE) EBITDA US GAAP (quarter values) |
||||||||
| 2024Q1 | 2024Q2 | 2024Q3 | 2024Q4 | 2024Q4 | LTM ? | |||
| EBITDA, bln rub | ? | 76.7 | 52.9 | 69.5 | 61.7 | 78.8 | 263.0 | |
| Changes by years, y/y, % | +44% | -25% | +4% | +4% | +33% | |||
| Changes by quarters, q/q, % | +30% | -31% | +31% | -11% | +28% | |||
